CJC-1295 + Ipamorelin (5mg/5mg) · Research brief

How to Calculate CJC-1295 Concentration? (Peptide Dosing)

Real Peptides Research TeamEditorial

Updated July 9, 20269 min read

60 WORDS

Short answer

Research conducted at the University of Texas Medical Branch found that nearly 40% of peptide dosing errors in laboratory settings stem from incorrect concentration calculations during reconstitution. Not from injection technique or storage failures. The math itself becomes the failure point when researchers assume that adding 2mL of bacteriostatic water to a 2mg lyophilized peptide automatically yields 1mg/mL without accounting…

Key takeaways

The peptide mass stated on the vial label (verified fill mass) is 10–20% higher than the nominal vial size in most research-grade peptides, and using nominal size instead of verified mass introduces systematic dosing error across every injection.
To calculate CJC-1295 concentration accurately, divide verified peptide mass (mg) by bacteriostatic water volume (mL). A 2.3mg vial reconstituted with 2mL water yields 1.15mg/mL, not 1mg/mL.
Standard insulin syringes measure in 0.01mL increments, so reconstitution volumes should be chosen to produce per-dose injection volumes between 0.1mL and 0.5mL for maximum measurement precision.
Displacement volume for peptides at the 2–5mg research scale contributes less than 0.25% error to final concentration and can be safely ignored in non-clinical applications.
Once concentration is calculated, injection volume per dose is determined by dividing desired dose (mg) by concentration (mg/mL). A 0.3mg dose from 1.15mg/mL solution requires 0.26mL or 26 syringe units.

Our team has guided hundreds of researchers through peptide reconstitution protocols across multiple compound classes. The gap between doing it right and doing it wrong comes down to three things most guides never mention: reading the vial label's stated mass (not the marketed size), understanding that bacteriostatic water volume and final solution volume aren't identical, and building a concentration calculation system that works backward from your target dose rather than forward from arbitrary dilution ratios.

How do you calculate CJC-1295 concentration after reconstitution?

To calculate CJC-1295 concentration, divide the peptide mass stated on the vial label (typically 2mg or 5mg) by the total volume of bacteriostatic water added during reconstitution. For example: 2mg peptide ÷ 2mL water = 1mg/mL concentration. This calculation assumes negligible displacement volume for small peptide masses and provides the baseline concentration needed to determine per-dose injection volumes using the formula: desired dose (mg) ÷ concentration (mg/mL) = injection volume (mL).

Most researchers assume the vial size printed on the product label represents the exact peptide mass inside. It doesn't. A vial marketed as '5mg CJC-1295' often contains 5.2mg, 5.5mg, or even 6mg of actual peptide to account for manufacturing overfill and handling loss. The certificate of analysis (COA) or the small print on the vial itself states the verified fill mass, and that's the number you must use to calculate CJC-1295 concentration accurately. Using the nominal size instead of the verified mass introduces a 4–20% dosing error that accumulates across every injection in a research protocol. This article covers how to read vial labels correctly, how displacement volume affects final concentration, and what preparation mistakes negate dosing accuracy entirely.

Step 1: Verify the Actual Peptide Mass from the Vial Label

Before you calculate CJC-1295 concentration, locate the verified fill mass printed on the vial label or stated in the certificate of analysis. Lyophilized peptides are manufactured with deliberate overfill. Typically 10–20% above the nominal vial size. To compensate for material loss during freeze-drying, handling, and the first reconstitution. A vial labeled '2mg CJC-1295' routinely contains 2.2–2.4mg of actual peptide, and using 2mg in your calculation when the vial contains 2.3mg means every dose you draw will be 15% stronger than intended.

The verified mass appears in one of three places: directly on the vial as a handwritten or printed figure (e.g., '2.34mg'), on a separate COA shipped with the peptide, or on the supplier's online batch verification page using the lot number printed on the vial. Real Peptides includes verified mass documentation with every research-grade peptide because dosing precision in biological research depends on knowing exactly what you're working with. Not what the marketing label says you ordered.

Researchers who skip this step and calculate CJC-1295 concentration using nominal vial size encounter two problems: underdosing when the actual fill is higher than nominal (wasting material and producing inconsistent results), and overdosing when they assume perfect fill accuracy in a manufacturing process that deliberately errs on the side of overfill. The five seconds it takes to read the verified mass prevents weeks of data inconsistency.

Step 2: Select Bacteriostatic Water Volume Based on Target Dose Precision

The volume of bacteriostatic water you add determines your final concentration, and that concentration determines how precisely you can measure each dose with standard insulin syringes. To calculate CJC-1295 concentration that allows for accurate small-volume dosing, work backward from your target research dose rather than forward from arbitrary round-number dilutions.

Standard insulin syringes measure volume in 0.01mL increments (1 unit = 0.01mL on a U-100 syringe). If your target CJC-1295 dose is 0.25mg and you reconstitute a 2mg vial with 2mL bacteriostatic water (yielding 1mg/mL concentration), you'll need to draw 0.25mL per dose. That's 25 units on the syringe, well within the precision range. But if you reconstitute that same 2mg vial with 1mL water (yielding 2mg/mL), your 0.25mg dose becomes 0.125mL or 12.5 units, which is harder to measure consistently and increases the risk of drawing 13 units (0.26mg) or 12 units (0.24mg) instead.

The standard reconstitution volumes for CJC-1295 are 2mL for 2mg vials and 5mL for 5mg vials, producing 1mg/mL concentration across both sizes. This isn't arbitrary. It's calibrated to produce per-dose volumes between 0.1mL and 0.5mL for the most common research dosing ranges (100mcg to 500mcg), which fall comfortably within insulin syringe precision limits. Researchers targeting doses outside that range should adjust their reconstitution volume accordingly: smaller target doses require more dilute solutions (lower concentration), and larger target doses tolerate more concentrated solutions (higher concentration) without sacrificing measurement precision.

Step 3: Apply the Concentration Formula and Calculate Injection Volume Per Dose

Once you've verified the peptide mass and selected your bacteriostatic water volume, calculate CJC-1295 concentration using this formula: Concentration (mg/mL) = Peptide Mass (mg) ÷ Water Volume (mL). Then calculate injection volume per dose using: Injection Volume (mL) = Desired Dose (mg) ÷ Concentration (mg/mL).

Example 1: A vial contains 2.3mg CJC-1295 (verified mass), reconstituted with 2mL bacteriostatic water. Concentration = 2.3mg ÷ 2mL = 1.15mg/mL. For a 0.3mg research dose: 0.3mg ÷ 1.15mg/mL = 0.26mL injection volume (26 units on a U-100 syringe).

Example 2: A vial contains 5.1mg CJC-1295, reconstituted with 5mL water. Concentration = 5.1mg ÷ 5mL = 1.02mg/mL. For a 0.25mg dose: 0.25mg ÷ 1.02mg/mL = 0.245mL injection volume (24.5 units, rounded to 25 units).

The displacement volume of the lyophilized peptide. The physical space the powder occupies before dissolving. Is negligible for CJC-1295 at research-scale masses. A 2mg peptide cake displaces approximately 0.002–0.005mL of solution volume, which introduces less than 0.25% error in final concentration and falls well within acceptable dosing tolerance for non-clinical research applications. Pharmaceutical-grade production accounts for displacement when calculating fill volumes for therapeutic peptides, but at the 2–5mg scale typical of research vials, the error introduced by ignoring displacement is smaller than the measurement precision of the syringe itself.

CJC-1295 Reconstitution: Method Comparison

Reconstitution Method	Concentration Achieved	Target Dose Range	Injection Volume Range	Measurement Precision	Professional Assessment
2mg vial + 2mL water	1mg/mL (assumes 2mg exact)	0.1–0.5mg per dose	0.1–0.5mL (10–50 units)	High. Well within syringe precision	Standard method for most research applications. Injection volumes fall in the sweet spot for accurate measurement with insulin syringes
2mg vial + 1mL water	2mg/mL (assumes 2mg exact)	0.2–0.8mg per dose	0.1–0.4mL (10–40 units)	Moderate. Smaller volumes increase relative measurement error	Useful when vial access is limited or when higher per-dose volumes aren't practical, but requires more careful syringe technique
5mg vial + 5mL water	1mg/mL (assumes 5mg exact)	0.1–0.5mg per dose	0.1–0.5mL (10–50 units)	High. Matches 2mg/2mL dilution precision	Preferred for extended research protocols requiring multiple doses from a single vial. Minimizes freeze-thaw cycles
5mg vial + 2mL water	2.5mg/mL (assumes 5mg exact)	0.25–1mg per dose	0.1–0.4mL (10–40 units)	Moderate. Higher concentration reduces margin for measurement error	Only appropriate when research protocols require doses above 0.5mg and vial longevity isn't a concern

What If: CJC-1295 Concentration Scenarios

What If the Vial Label Shows a Range Instead of an Exact Mass?

Use the midpoint of the stated range as your calculation input. If the label reads '2.0–2.4mg,' calculate CJC-1295 concentration using 2.2mg as the peptide mass. The range represents the manufacturer's verification tolerance, and the midpoint provides the statistically most likely fill mass. For research applications requiring tighter dosing precision, contact the supplier for the exact verified mass tied to that specific lot number. Reputable suppliers maintain batch records that specify fill mass to the nearest 0.01mg.

What If I Want to Change the Concentration After Reconstitution?

You can't remove water once it's added, so dilution is irreversible. If you've reconstituted a 2mg vial with 1mL water (2mg/mL) and decide you want 1mg/mL instead, you'll need to add another 1mL bacteriostatic water to the same vial, which dilutes the solution to the target concentration. The peptide remains stable through this secondary dilution as long as you use sterile technique and the total reconstitution time stays within the peptide's room-temperature stability window (typically under 30 minutes for lyophilized CJC-1295 before refrigeration).

What If the Syringe Markings Don't Align with My Calculated Dose Volume?

Round to the nearest measurable increment rather than attempting to estimate between markings. If your calculated injection volume is 0.245mL (24.5 units) and your syringe measures in whole units, draw 25 units instead of trying to eyeball the halfway point between 24 and 25. The rounding error. 0.005mL or roughly 2% of dose. Is smaller than the variability introduced by attempting to measure fractional syringe units by eye. For protocols requiring doses that consistently fall between syringe markings, reconstitute with a different water volume to shift the concentration until your target doses align with whole syringe units.

The Practical Truth About Peptide Concentration Math

Here's the honest answer: most researchers who run into dosing inconsistencies blame their injection technique or peptide degradation when the actual problem is that they calculated CJC-1295 concentration using the wrong starting number. The vial says '2mg' in large print, so they use 2mg in the formula, and they never realize the small print on the back says '2.38mg verified'. Which means every dose they've drawn for the past month has been 19% stronger than intended. That's not a storage failure or a supplier quality issue. That's a failure to read the label.

The second most common mistake is reconstituting with round-number water volumes that produce concentrations requiring fractional syringe measurements. A 2mg vial reconstituted with 1.5mL water yields 1.33mg/mL concentration, and suddenly a 0.25mg dose requires drawing 0.1875mL. Which is 18.75 units on a syringe that measures in whole-unit increments. Researchers either guess at three-quarters of the way between 18 and 19 units, or they convince themselves they can reliably measure 0.005mL differences by eye. They can't. The solution isn't better eyesight or steadier hands. It's choosing a reconstitution volume that produces a concentration where your target dose lands on a whole syringe unit. That's not dumbing down the science; that's acknowledging that measurement tools have precision limits and working within them instead of pretending they don't exist.

The formula to calculate CJC-1295 concentration is deliberately simple. Peptide mass divided by water volume. Because the complexity isn't in the math. It's in verifying what numbers to plug into the formula before you start calculating. Get those inputs right, and the rest is arithmetic.

If you're working with research-grade peptides and need verified mass documentation that doesn't require hunting through PDFs or calling customer service, Real Peptides includes batch-specific fill mass on every vial label and COA. Precision in peptide research starts with knowing exactly what you're reconstituting. The rest is just following the formula.

References

Peer-reviewed sources on CJC-1295 indexed in PubMed, listed for research context. Real Peptides supplies CJC-1295 for laboratory research use only.

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Substance use & misuse, 2016. PMID 26771670. doi:10.3109/10826084.2015.1082595
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug testing and analysis, 2010. PMID 21204297. doi:10.1002/dta.233
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009. PMID 19386527. doi:10.1016/j.ghir.2009.03.001
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism, 2006. PMID 16352683. doi:10.1210/jc.2005-1536
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American journal of physiology. Endocrinology and metabolism, 2006. PMID 16822960. doi:10.1152/ajpendo.00201.2006
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of clinical endocrinology and metabolism, 2006. PMID 17018654. doi:10.1210/jc.2006-1702
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology, 2005. PMID 15817669. doi:10.1210/en.2004-1286

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Contact the supplier directly with the lot number printed on the vial and request the certificate of analysis, which contains the verified fill mass for that specific batch. If the supplier can’t provide this documentation, assume the vial contains the nominal mass stated on the label and note that your dosing accuracy may vary by 10–20%. Reputable peptide suppliers maintain batch records with verified mass data for every lot produced — if they don’t, that’s a red flag about their quality control practices.

Yes — multiply the mg/mL concentration by 1,000 to convert to mcg/mL. A 1mg/mL solution equals 1,000mcg/mL, and a 2.5mg/mL solution equals 2,500mcg/mL. Some researchers prefer mcg/mL notation because research doses are often expressed in micrograms (e.g., 250mcg per injection), which eliminates the decimal-point conversions required when working in milligrams. The underlying math doesn’t change — only the units used to express the result.

Overdosing CJC-1295 in research models produces dose-dependent side effects including transient hypoglycemia, increased appetite suppression, and elevated growth hormone release beyond the intended protocol range. The severity depends on how far above the target dose you’ve gone — a 20% overdose may produce subtle protocol deviations, while a 2× overdose could compromise the entire dataset. If you discover a calculation error mid-protocol, document the actual doses administered, recalculate the correct concentration, and determine whether the deviation falls within acceptable variance for your research objectives before deciding whether to continue or restart.

Reconstituted CJC-1295 stored at 2–8°C in bacteriostatic water maintains ≥95% of its initial concentration for 28 days, after which degradation accelerates and the actual peptide concentration begins to fall below the calculated value. The concentration formula assumes the peptide remains stable — once degradation begins, the calculated concentration no longer reflects the active peptide content in the vial. For research protocols extending beyond 28 days, reconstitute smaller vial sizes more frequently rather than storing a single large vial for months.

No — the concentration formula depends only on peptide mass and water volume, not the water composition. Bacteriostatic water (0.9% benzyl alcohol in sterile water) and bacteriostatic sodium chloride (0.9% benzyl alcohol in 0.9% saline) both work identically for concentration calculations. The benzyl alcohol prevents bacterial growth during multi-dose use, but it doesn’t alter the volume or dissolve the peptide differently. Use whichever bacteriostatic solution your protocol specifies, and the math stays the same.

Yes — divide the verified peptide mass by the total volume of water you actually added, not the volume you intended to add. If you meant to add 2mL but accidentally added 2.5mL to a 2mg vial, your actual concentration is 2mg ÷ 2.5mL = 0.8mg/mL. Recalculate your per-dose injection volumes using the new concentration. The peptide is still usable — you’ll just need to draw larger volumes per dose to hit your target dose in milligrams.

Nominal vial size is the marketed product size (e.g., ‘2mg vial’ or ‘5mg vial’) used for ordering and labeling, while verified mass is the actual peptide content measured and documented for that specific production batch. Verified mass is always equal to or higher than nominal size due to manufacturing overfill practices — using nominal size in your calculation when the vial contains more peptide will cause you to systematically underdose every injection.

Add the verified masses of all vials together, then divide by the total volume of bacteriostatic water used across all vials. If you reconstitute three 2mg vials (verified masses: 2.2mg, 2.3mg, 2.1mg) with 6mL total water, the combined concentration is (2.2 + 2.3 + 2.1)mg ÷ 6mL = 1.1mg/mL. This approach is common in large-scale research protocols but requires sterile technique throughout to prevent contamination during the transfer process.

CJC-1295 is a 30-amino-acid peptide with a molecular weight around 3.6 kDa, which produces a very small lyophilized powder mass — 2mg of CJC-1295 occupies roughly 0.002mL of physical space once dissolved. Larger proteins like human growth hormone (22 kDa, 5–10mg per vial) displace 0.05–0.1mL of solution volume, which introduces measurable error if ignored. At the 2–5mg scale typical of research peptides, displacement contributes less error than the measurement precision of the syringe itself.

Yes — both forms use the identical formula: peptide mass divided by water volume. CJC-1295 DAC (drug affinity complex) has a slightly higher molecular weight due to the attached maleimidoproprionic acid linker, but the concentration calculation doesn’t change because you’re working with verified mass in milligrams, not molar concentration. The DAC modification affects half-life and dosing frequency in biological systems, not the reconstitution math.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA